China SXT Pharmaceuticals (SXTC) Stock Climbs On SEC Filing

China SXT Pharmaceuticals SXTC Stock News

Stock & ETF Trading Signals

China SXT Pharmaceuticals Inc (NASDAQ: SXTC) is screaming for the top in the market this morning. However, with no press releases out, there are plenty of investors wondering what’s going on. The gains seem to be the result of a recent SEC filing. Here’s the scoop:

Attention Alpha Stock News Readers: You have FREE access to Joshua Rodriguez’s investing portfolio. Click here!

SXTC Stock Rockets On SEC Filing

As mentioned above, China SXT Pharmaceuticals hasn’t issued any press releases. However, an SEC filing seems to be creating quite a bit of excitement.

In the filing, SXTC said that it has entered into a securities purchase agreement with Mr. Xing Yuan. The agreement surrounds the sale of 12 million shares at a per share price of $0.60. The transaction will bring $7.2 million into the company at an incredible premium.

In the filing, the company said that it has also entered into a voting agreement with Mr. Feng Zhou, who owns 8.5 million shares of the company, representing 13.68% voting power. According to the agreement, Mr. Yuan has irrevocably granted his power of attorney to Mr. Zhou, for the maximum time period permitted by law.

Finally, SXTC said that Mr. Tulin Lu resigned from his position as a director on November 24, 2020 for personal reasons. As a result, Mr. Yuan has been appointed to the company’s Board to fill the vacancy. The resignation of Mr. Lu and appointment of Mr. Yuan will take place upon the closing of the agreement.

Moreover, should Mr. Yuan hold less than 1.2 million ordinary shares at any given time, he will be dismissed from the Board of Directors.

Finally, SXTC said that it has made full payment of the forbearance redemption amounts in accordance with the Forbearance Agreements entered into with two investors on December 16, 2019 and March 4, 2020.

Seriously, Joshua shares 100% of his portfolio positions with Alpha Stock News readers here!

This Is Exciting News

While China SXT Pharmaceuticals didn’t issue any press releases, the compay’s SEC filing did the trick. Ultimately, we’re going to see a change in the Board of Directors after a large investor has stepped in and taken a massive interest in the company at a premium. That’s exciting no matter how you slice it, making SXTC a stock that’s well worth watching.

Don’t Miss The Next Big Story

Join our free mailing list below to receive real-time news alerts and gain access to Joshua’s investing portfolio!

Subscribe Now

All we need is your email address.

Click here to subscribe if reading on mobile. 

Top Trading Services

ServiceTrade Ideas
eToro
Investors Underground
Day Trading Lessons
Key Features– AI-Based Trade Ideas
– Simulated Trading
– Alert Windows
– Quality Charting Tools
– One Click Trading
– Automated Trading
– Copy successful Traders
– Get Copied Get Paid
– $0 Commissions
– Educational Resources
– Premarket Broadcast
– Live Trading Floor
– Nightly Watch List
– Morning Call
– 1,000+ Video Lessons
Rating4.7 out of 54.5 out of 54.2 out of 5
Price$118 – $228 per month
or
$1,068 – $2,268 per year
FREE$297 per month,
$697 per quarter, or
$1,897 per year
Sign UpSign Up Now!Sign Up Now!Sign Up Now!

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.